The ethics of biodefense

Bioethics

Volumn 19, Issue 4, 2005, Pages 432-446

  King, Nicholas B ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTHRAX; BIOSAFETY; CANCER; EPIDEMIC; ETHICS; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; REVIEW; SOCIAL SECURITY; TERRORISM; THREAT; UNITED STATES; VACCINATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH; WAR AND HUMAN RIGHTS ABUSES;

BIOLOGICAL WARFARE; BIOMEDICAL RESEARCH; BIOTERRORISM; CIVIL RIGHTS; CONFIDENTIALITY; CONTAINMENT OF BIOHAZARDS; DISASTER PLANNING; DISEASE OUTBREAKS; EPIDEMIOLOGY; HUMANS; IMMUNIZATION PROGRAMS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PUBLIC HEALTH ADMINISTRATION; PUBLIC POLICY; PUBLISHING; RESOURCE ALLOCATION; RISK ASSESSMENT; UNITED STATES;

EID: 23944436502     PISSN: 02699702     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-8519.2005.00454.x     Document Type: Review

References (52)

1. A. Schuler. Billions for Biodefense: Federal Agency Biodefense Funding, FY2001-FY2005. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2004; 2: 86-96.
2. J.B. Tucker. 2000. Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons. Cambridge. MIT Press.
3. Walter Laqueur. Postmodern Terrorism. Foreign Affairs 1996; 75: 24-36.
4. E.K. Noji. Hazardous World: The Real Risk of Bioterrorism. Georgetown Journal of International Affairs 2001; 11: 33-44;
5. R.A. Falkenrath, R.D. Newman & B.A. Thayer. 1998. America's Achilles Heel: Nuclear, Biological, and Chemical Terrorism and Covert Attack. Cambridge. MIT Press.
6. Centers for Disease Control and Prevention. Biological and Chemical Terrorism: Strategic Plan for Preparedness and Response. Recommendations of the CDC Strategic Planning Workgroup. Morbidity and Mortality Weekly Report. 2000; 49: 1-14;
7. C.F. Chyba. 1998. Biological Terrorism, Emerging Diseases, and National Security. New York. Rockefeller Brothers Fund, Inc.
8. N.B. King. The Scale Politics of Emerging Diseases. Osiris 2004; 19: 62-76;
9. E. Fee & T.M. Brown. Preemptive Biopreparedness: Can We Learn Anything from History? American Journal of Public Health 2001; 91: 721-726.
10. V.W. Sidel, R.M. Gould & H.W. Cohen. Bioterrorism Preparedness: Cooptation of Public Health? Medicine and Global Survival 2002; 7: 82-89.
11. E. Fee & T.M. Brown. The Unfulfilled Promise of Public Health: Deja Vu All Over Again. Health Affairs 2002; 21: 31-43;
12. H.J. Geiger. Terrorism, Biological Weapons, and Bonanzas: Assessing the Real Threat to Public Health. American Journal of Public Health 2001; 91: 708-709.
13. T. May. Book Review: Public Health in an Era of Terrorism. American Journal of Bioethics 2003; 3: W12.
14. H.W. Cohen, R.M. Gould & V.W. Sidel. The Pitfalls of Bioterrorism Preparedness: the Anthrax and Smallpox Experiences. American Journal of Public Health 2004; 94: 1669.
15. General Accounting Office. Bioterrorism: Preparedness Varied Across State and Local Jurisdictions. April 2003. GAO-03-373: 17.
16. E. Gursky. Progress and Peril: Bioterrorism Preparedness Dollars and Public Health. Washington, D.C. The Century Foundation. January 2004: 30.
17. The National Association of County and City Health Officials. Impact of Smallpox Vaccination Program on Local Public Health Services. Research Brief. February 2003, No. 9.
18. G. Markowitz & D. Rosner. 2004. Emergency Preparedness, Bioterrorism, and the States: The First Two Years after September 11. New York. Milbank Memorial Fund;
19. Trust for America's Health. 2003. Ready or Not? Protecting the Public's Health in the Age of Bioterrorism. Washington, D.C.
20. J.R. Smith. The Dark Side of Biotechnology. Science 1984; 224: 1215;
21. C. Norman. Biologists Eschew Weapons Research. Science 1988; 241: 650.
22. J. Kempner, C.S. Perlis & J.F. Merz. Forbidden Knowledge. Science 2005; 307.
23. M. Meselson, J. Guillemin, M. Hugh-Jones, A. Langmuir, I. Popova, A. Shelokov & O. Yampolskaya. The Sverdlovsk Anthrax Outbreak of 1979. Science 1994; 266: 1202-1208.
24. S. Shane. Exposure at Germ Lab Reignites a Public Health Debate. The New York Times, January 24 2005.
25. J.D. Moreno. Bioethics After the Terror. American Journal of Bioethics 2002; 2: 62.
26. R.J. Jackson, A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall & I.A. Ramshaw. Expression of Mouse Interleukin-4 by a Recombinant Ectomelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox. Journal of Virology 2001; 75: 1205-1210.
27. A. Harmon. Journals to Consider U.S. Security in Publishing. The New York Times. New York 2003.
28. G. Kwik, J. Fitzgerald, T.V. Inglesby & T. O'Toole. Biosecurity: Responsible Stewardship of Bioscience in an Age of Catastrophic Terrorism. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2003; 1: 27-35;
29. E.R. Parker & L.G. Jacobs. Government Controls of Information and Scientific Inquiry. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2003; 1: 83-95.
30. A. Baciu, A. Anason, K. Stratton & B. Strom, eds. 2005. The Smallpox Vaccination Program: Public Health in an Age of Terrorism. Washington, D.C. National Academies Press: 173, 73.
31. H.A. Taylor & R.R. Faden. Ethical Considerations in the Formation of Smallpox Vaccine Policy. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2003; 1: 47-52;
32. T. May & R.D. Silverman. Should Smallpox Vaccine be Made Available to the General Public. Kennedy Institute of Ethics Journal 2003; 13: 67-82.
33. R.B. Quigley. Uncertain Benefit: The Public Policy of Approving Smallpox Vaccine Research. American Journal of Public Health 2004; 94: 943-946;
34. T. May, M. P. Aulisio & R.D. Silverman. The Smallpox Vaccination of Health Care Workers: Professional Obligations and Defense Against Bioterrorism. Hastings Center Report 2003; 33: 26-33.
35. R. Bayer & J. Colgrove. Bioterrorism, Public Health, and the Law. Health Affairs 2002; 21: 98-101;
36. L.O. Gostin. Public Health Law in an Age of Terrorism: Rethinking Individual Rights and Common Goods. Health Affairs 2002; 21: 79-93;
37. G. Annas. Bioterrorism, Public Health, and Civil Liberties. New England Journal of Medicine 2002; 246: 1337-1342.
38. V.T. Covello, R.G. Peters, J.G. Wojtecki & R.C. Hyde. Risk communication, the West Nile virus epidemic, and bioterrorism: responding to the communication challenges posed by the intentional or unintentional release of a pathogen in an urban setting. Journal of Urban Health 2001; 78: 382-91.
39. T.A. Glass and M. Schoch-Spana. Bioterrorism and the People: How to Vaccinate a City Against Panic. Clinical Infectious Diseases 2002; 34: 217-223.
40. A bioterrorist might also intentionally infect him- or herself with a highly virulent agent as part of a suicide mission.
41. J.A. Pavlin. Epidemiology of Bioterrorism. Emerging Infectious Diseases 1999; 5: 528-530;
42. C.F. Chyba. 1998. Biological Terrorism, Emerging Diseases, and National Security. New York. Rockefeller Brothers Fund, Inc.
43. A.L. Fairchild. Dealing with Humpty Dumpty: Research, Practice, and the Ethics of Public Health Surveillance. The Journal of Law, Medicine, and Ethics 2003; 31: 615-623.
44. A. Reingold. If Syndromic Surveillance is the Answer, What is the Question? Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2003; 1: 77-81.
45. M. Leitenberg. Biological Weapons and Bioterrorism in the First Years of the Twenty-First Century. Politics and the Life Sciences 2002; 21: 3-27.
46. S. Wright. 1990. Preventing a Biological Arms Race. Cambridge. MIT Press.
47. G.M. Gray & D.P. Ropeik. Dealing with the Dangers of Fear: The Role of Risk Communication. Health Affairs 2002; 21: 106-116.
48. I. Kickbush. Influence and Opportunity: Reflections on the U.S. Role in Global Public Health. Health Affairs 2002; 21: 131-141.
49. E.L. Baker, Jr. & J.P. Koplan. Strengthening the Nation's Infrastructure: Historic Challenge, Unprecedented Opportunity. Health Affairs 2002; 21: 23.
50. N.B. King. Security, Disease, Commerce: Ideologies of Post-Colonial Global Health. Social Studies of Science 2002; 32: 763-789.
51. J.F. Childress. 2003. Triage in Response to a Bioterrorist Attack.; and K. Kipnis. 2003. Overwhelming Casualties: Medical Ethics in a Time of Terror. In In the Wake of Terror: Medicine and Morality in a Time of Crisis. J.D. Moreno, ed. Cambridge. MIT Press.
52. The author thanks Jennifer Fishman for suggesting this as a useful distinction.